Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Physiomics ( (GB:PYC) ) just unveiled an announcement.
Physiomics plc announced the release of its audited financial results for the year ending 30 June 2025, scheduled for 29 September 2025. Following a merger, Moore Kingston Smith LLP will now serve as the company’s ongoing auditors. A live presentation by the CEO and Non-Executive Chairman will be held on 1 October 2025 to discuss the results and provide a business update, accessible to existing and potential shareholders through the Investor Meet Company platform. This announcement highlights Physiomics’ commitment to transparency and engagement with its stakeholders, potentially strengthening its position in the industry.
Spark’s Take on GB:PYC Stock
According to Spark, TipRanks’ AI Analyst, GB:PYC is a Underperform.
Physiomics’ stock score is primarily impacted by significant financial instability, including declining revenues and negative profit margins. Technical indicators reinforce a bearish outlook. While recent corporate events suggest potential growth pathways, current valuation issues and financial challenges remain significant obstacles.
To see Spark’s full report on GB:PYC stock, click here.
More about Physiomics
Physiomics plc is a leading company in mathematical modelling and data science, focusing on developing new therapeutics and personalized medicine solutions. The company combines expertise in Modelling & Simulation, Biometrics, Data Science, and Bioinformatics to assist biotech and pharma companies in streamlining their drug development processes. With its proprietary Virtual Tumour technology, Physiomics has contributed to over 100 commercial projects, serving clients like Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics, and CRUK.
Average Trading Volume: 3,285,208
Technical Sentiment Signal: Sell
Current Market Cap: £1.52M
Learn more about PYC stock on TipRanks’ Stock Analysis page.